Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient;Criterios de riesgo de bacteriemia en el paciente oncológico neutropénico febril pediátrico

Clinical and Translational Oncology

Volumn 7, Issue 4, 2005, Pages 165-168

  Peralta, Sandra Gala ^a   Salzman, Teresa Cardesa ^a   García, Juan José García ^a   Aguado, Jesús Estella ^b   Giralt, Amadeu Gené ^b   Cubells, Carles Luaces ^a  

^a Hospital Sant Joan de Déu   (Spain)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Febrile neutropenia; Low risk factors; Pae diatric oncology

Indexed keywords

ADOLESCENT; ARTICLE; BACTEREMIA; CHILD; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; MALE; NEOPLASM; NEUTROPENIA; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS; NEUTROPENIA; RISK FACTORS;

EID: 24344496124     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/BF02708754     Document Type: Article

References (12)

1. Mustafa M, Aquino M, Pappo A., et al A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteraemia. J Pediatr. 1996; 128(6): 847-9.
2. a ed. Philladelphia: Editorial Lippincott Williams & Wilkins; 2000. p. 353-78.
3. Baorto EP, Quino M, Buchanan G.R., et al Clinical parameters associated with low bacteriemia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001; 92(4): 909-13.
4. Wehl G, Allerberger F, Heitger A., Meister B, Maurer K, Fink FM Trends in infection morbidity in a pediatric oncology ward. Med Pediatr Oncol. 1999; 32: 336-43.
5. Alexander SW, Wde KD, Hibberd P.L., Parson SK Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2002; 39(2): 77-85.
6. Orudjev E, Lange BJ Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol. 2002; 39(2): 77-85.
7. Lucas KG, Brown AE, Armstrong D, Chapman D., Heller G. The identification of febrile, neutropenic children with neoplasic disease and low risk for bacteriemia and complications of sepsis. Cancer. 1996; 77: 791-8.
8. Choi CW, Sung HJ, Park K.H., et al Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia. Am J Hematol. 2003; 73(4): 263-6.
9. Muller J, Kovacs G, Garami M., Schmidt M, Fekete G. Meropenem therapy in children with febrile neutropenia. Orv Hetil. 2003; 144(43): 2115-20.
10. Ammann RA, Hirt A, Luthy A.R., Aebi C. Identificación of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol. 2003; 41(5): 436-43.
11. Holdsworh M, Hanrahan J, Albanese B., Frost J. Outpatient management of febrile neutropenia in children with cancer. Paediatr Drugs. 2003; 5(7): 443-55.
12. Karthaus M, Egerer G, Kullmann K.H., Ritter J., Jurgens H. Ceftriaxone monotherapy in the treatment of low risk febrile neutopenia. Chemotherapy. 1998; 44(5): 343-54.